Vabysmo 6 MG/0.05 ML vial 0.05ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQPW5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,652
Award facts
- Contract value 100% obligated
- $44,651.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $44,651.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Vabysmo 6 mg/0.05 ml vials. The delivery order, issued on December 9, 2025, is structured as a firm fixed-price contract with an ultimate completion date of December 31, 2025. This award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the sole awardee with no identified subcontractor relationships.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support the Department of Defense's global pharmaceutical supply chain. The parent IDC, awarded on November 13, 2025, carries a $500 million ceiling and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to supply branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. The contractor's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQPW5?
SPE2DR26FQPW5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FQPW5 worth?
The government has obligated $44,652 on SPE2DR26FQPW5.
Is contract SPE2DR26FQPW5 an order under another contract?
Yes. SPE2DR26FQPW5 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPW5 competed?
The extent of competition for SPE2DR26FQPW5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award